Our Products

Product name

Dosage Form

Strength

Therapeutic Category

Status

1

Alimemazine**

oral solution

7.5mg/5ml, 10mg/5ml, 30mg/5ml

Antihistamine/mild sedative

Marketed in UK

2

Calcium Polystyrene Sulfonate

powder for oral / rectal suspension 

99,934% w/w

Treatment of hyperkalemia

Marketed in UK

3

Carbocisteine

oral solution

250mg/5ml
750mg/5ml, 750mg/sachet

Mucolytic

Marketed in UK

4

Oxybutynin

oral solution

2.5mg/5ml, 5mg/5ml

Anticholinergic / antispasmodic 

Marketed in UK

5

Oxycodone

oral solution

5mg/5ml, 2mg/ml, 10mg/ml
4mg/ml, 5mg/sachet,
10mg/sachet, 20mg/sachet

Opioid analgesic

Marketed in UK, Nordics

6

Sodium Oxybate

oral solution

500mg/ml

CNS depressant (Narcolepsy & Cataplexy) 

Marketed in UK, NL, ES, SE, DK 

7

Tramadol

oral solution

50mg/5ml, 100mg/5ml

Opioid analgesic

Marketed in UK

8

Docusate Sodium

oral solution

12.5mg/5ml, 50mg/5ml,
100mg/5ml, 12.5mg/sachet,
50mg/sachet, 100mg/sachet

Laxative

Marketed in UK

9

Fludrocortisone*

oral solution
0.1mg/ml

Corticosteroid-Hormone deficiency

Marketed in UK, FR

10

Methylphenidate

oral solution
10mg/5ml

ADHD

Marketed in UK, Under registration in Nordics, DE

11

Ondansetron*

oral solution

4mg/5ml, 8mg/5ml

Antiemetic

Marketed in UK

12

Sodium Bicarbonate

oral solution

420mg/5ml (or 84mg/ml)

Antacid

Marketed in UK

13

Tramadol + Paracetamol*

oral solution
(37.5+325)mg/5ml

Combined opioid/non-opioid pain reliever

Registered in EU

14

Prednisolone (as sodium phosphate) 

suppository

5mg

Corticosteroid

Under registration  in UK

15

Liothyronine*

oral solution

10mg/ml

Thyroid Hormone

Under registration in UK

16

Atropine

eye drops

1 % w/v

antimuscarinic agent used as a cycloplegic and mydriatic

Registered in UK

17

Ramipril

oral solution

2.5mg/5ml

ACE inhibitor

Under registration in UK

18

Diazepam***

oral solution

2mg/5ml, 5mg/5ml

Anxiolytic, sedative

Under registration in UK

19

Lisdexamfetamine****

oral solution

10mg/ml

ADHD

Under registration in EU

20

Sevelamer

oral suspension
800 mg/10ml, 800mg/sachet, 1600mg/sachet, 2400mg/sachet

Treatment of hyperphosphataemia

Under registration in UK

Notes:

  • Green highlighted forms and strengths denote Added Value hybrid products (unique dosage forms and/or strengths).
  • Products marked with (*) are co-developed with HELM AG, who is liaised for licensing opportunities.
  • Products marked with (**) are co-developed with Lucis Pharma Limited, who is liaised for licensing opportunities.
  • Products marked with (***) are co-developed with Roma Pharmaceuticals Ltd., who is liaised for licensing opportunities.
  • Products marked with (****) are co-developed with Alvogen & Authenda, and Authenda is liaised for licensing opportunities.
  • All products developed, manufactured, and supplied by LABOMED (except solid/semi-solid forms where CMOs used for manufacturing).
  • Labomed owns 16 Patent applications to EPO & PCT.
Scroll to Top